23 Oct 24
our team

Sunil Shah
CEO - o2h Ventures and Co-Founder - o2h discovery
Sunil's Biography

Sunil Shah
CEO - o2h Ventures and Co-Founder - o2h discovery
A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University
Connect on linkedin

Prashant Shah
CEO - o2h discovery and Co-Founder - o2h group
Prashant's Biography

Prashant Shah
CEO - o2h discovery and Co-Founder - o2h group
Prashant is a serial entrepreneur in life sciences and tech in which one of those companies was acquired by a public company. He is currently active in seed investing (a portfolio of ~50 companies), product/IP development, services, and building lab/office infrastructure. The early career was with the Strategy group at Accenture. He has a BEng, an MSc, in which he worked on the Human Genome Program at the Sanger Centre, and an MPhil in Management from the Judge Institute. Prashant is also a General Partner in the o2h SEIS/EIS Human Health Funds.
Connect on linkedin

Andy Morley
Chief Scientific Officer
Andy's Biography

Andy Morley
Chief Scientific Officer
Andy is the Chief Scientific Officer (CSO) at o2h Discovery. He also leads scientific evaluations for investments and provides strategic scientific support across key portfolio projects for o2h Ventures. With over 25 years of experience as a Medicinal Chemist, Andy has worked with major pharmaceutical companies, including Sanofi-Aventis and AstraZeneca. He has contributed across all phases of drug discovery and has played a key role in advancing five candidates into clinical trials. Andy is also the author and inventor of over 55 publications and patents.
Connect on linkedin

Nilesh Dagia
Chief Special Projects Officer
Nilesh's Biography

Nilesh Dagia
Chief Special Projects Officer
Nilesh leads the global operations of o2h group covering a wide range of innovation led investment, life-science and technology businesses. He is also overseeing the development and execution of the new o2h discovery Shirish Research Centre in Ahmedabad, India. Prior to joining o2h group, Nilesh worked with Piramal Group in various capacities including as an Alliance Manager for a risk-share oncology-based collaboration with a US Big Pharma and has also worked as the Head of Biology in Piramal Discovery solutions. Nilesh obtained his Ph.D. from Ohio University and completed a post-doc in Immunology, Stem Cells and Regenerative Medicine at Harvard Medical School. He is the author and inventor of >30 life science patents and publications. He received the Young Scientist of India award from OPPI in 2010.
Connect on linkedin